Kallikrein 5 (KLK5) Peptide
-
- Antigène Tous les produits Kallikrein 5 (KLK5)
- Kallikrein 5 (KLK5)
- Type de proteíne
- Synthetic
- Origine
- Mammifères
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Séquence
- CDHPSNTVPS GSNQDLGAGA GEDARSDDSS SRIINGSDCD MHTQPWQAAL
- Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KLK5 antibody,
Alternative Names: KLK5 control peptide, KLK5 antibody Blocking Peptide, Anti-KLK5 Blocking Peptide, Kallikrein-Related Peptidase 5 Blocking Peptide, KLK-L2 Blocking Peptide, KLKL2 Blocking Peptide, SCTE Blocking Peptide, KLK5, KLK-5, KLK 5, KLK-5 Blocking Peptide, KLK 5 Blocking Peptide
-
-
- Indications d'application
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C long term.
-
- Antigène
- Kallikrein 5 (KLK5)
- Synonymes
- KLK-L2 Peptide, KLKL2 Peptide, SCTE Peptide, 1110030O19Rik Peptide, KAL Peptide, KALA Peptide, Klk1 Peptide, Klk5 Peptide, RATKALA Peptide, kallikrein related peptidase 5 Peptide, kallikrein related-peptidase 5 Peptide, kallikrein 5-like Peptide, KLK5 Peptide, Klk5 Peptide, Klk5l Peptide
- Sujet
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers.
- Poids moléculaire
- 25 kDa
-